BB
BBRRF.US Blueberries Medical Corp
- Market cap
- USD 4.72M
- P/E
- -
- P/B
- 233.89x
- ROE
- -2,619.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is BBRRF.US undervalued?
Graham numberThe Graham number of Blueberries Medical Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Blueberries Medical Corp fundamental analysis
No fundamental analysis for Blueberries Medical Corp yet.
Blueberries Medical Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Blueberries Medical Corp
Blueberries Medical Corp., a consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia. The company produces and distributes psychoactive and non-psychoactive cannabis derivatives. Blueberries Medical Corp. is based in Vancouver, Canada.
Full company profileBlueberries Medical Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Blueberries Medical Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 4.64K | 66.0K | 139K | 235K | 288K | 471K | 312K | 156K |
| Gross Profit | 0.00 | 0.00 | 0.00 | -294K | 62.4K | -245K | -17.7K | 84.2K | 165K | 49.5K | 98.7K |
| Operating Income | -414K | -55.2K | -1.62M | -10.8M | -3.41M | -961K | -1.34M | -1.38M | -913K | -1.38M | -665K |
| EBITDA | -412K | -1.60M | - | -6.53M | -3.41M | -961K | -1.34M | -1.22M | -1.04M | -1.28M | -660K |
| Net Income | -416K | -15.5K | -1.61M | -10.8M | -4.94M | -5.15M | -1.47M | -1.64M | -1.15M | -1.66M | -751K |
| EPS | -0.19 | -0.01 | - | -0.10 | -0.04 | -0.03 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 1.82K | 6.59K | 1.87M | 9.79M | 7.27M | 3.59M | 3.35M | 2.42M | 1.38M | 679K | 670K |
| Total Liabilities | 364K | 84.3K | 743K | 1.71M | 3.38M | 2.16M | 1.89M | 471K | 546K | 358K | 642K |
| Shareholders' Equity | -362K | -77.7K | 1.12M | 8.08M | 3.89M | 1.43M | 1.47M | 1.95M | 835K | 321K | 28.7K |
| Cash & Short-term Investments | 0.00 | 965.00 | 0.00 | 2.67M | 307K | 1.34M | 1.41M | 818K | 66.1K | 26.4K | 14.8K |
| Total Debt | 0.00 | 818.00 | - | 841K | 1.49M | 1.44M | 1.34M | 12.8K | 11.4K | 138K | 8.29K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -104K | -12.4K | -846K | -4.29M | -2.39M | -1.68M | -1.47M | -1.33M | -797K | -1.24M | -605K |
| Capital Expenditure | 0.00 | 0.00 | 35.7K | 4.53M | 611K | 48.8K | 0.00 | 22.4K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -104K | -12.4K | - | -8.83M | -3.00M | -1.73M | -1.47M | -1.35M | -797K | -1.24M | -605K |
| Ratios | |||||||||||
| ROE | - | - | -142.9% | -133.6% | -127.0% | -358.7% | -100.0% | -84.0% | -137.6% | -518.7% | -2,619.0% |
| ROA | -22,891.2% | -234.8% | -86.1% | -110.2% | -67.9% | -143.2% | -43.8% | -67.7% | -83.2% | -245.1% | -112.0% |
| Net Profit Margin | - | - | - | -232,297.1% | -7,487.5% | -3,709.6% | -623.4% | -567.3% | -243.6% | -533.4% | -481.5% |
| Debt to Equity | - | - | - | 0.10x | 0.38x | 1.00x | 0.91x | 0.01x | 0.01x | 0.43x | 0.29x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Blueberries Medical Corp dividends
Blueberries Medical Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Feb 8, 2019.
Who owns Blueberries Medical Corp
- Insiders 74.01%
- Institutions 0.00%
- Public & others 26.00%
- Shares outstanding 580M
- Free float 128M
Blueberries Medical Corp company profile
- Company name
- Blueberries Medical Corp
- Ticker
- BBRRF.US
- ISIN
- CA09609Y1016
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 8500 West Georgia Street, Vancouver, BC, Canada, V6C 3E8
- Phone
- 57 3 161 70133
- Website
- blueberriesmed.com
About Blueberries Medical Corp
Blueberries Medical Corp., a consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia. The company produces and distributes psychoactive and non-psychoactive cannabis derivatives. Blueberries Medical Corp. is based in Vancouver, Canada.
Blueberries Medical Corp management
3- Mr. Facundo GarretonExecutive Chairman & CEO · born 1974
- Mr. Thomas Pablo Rodriguez PratsChief Financial Officer
- Gustavo GutiérrezCountry Manager